期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

光动力疗法治疗渗出型老年性黄斑变性 被引量：7

原文传递
导出
摘要 光动力疗法(PDT)是目前治疗老年性黄斑变性(AMD)的脉络膜新生血管(CNV)较为安全有效的方法。本文综述了适于PDT治疗的CNV的特点和PDT的并发症。其中CNV的类型、病灶大小、位置及活动性对治疗效果影响较大,而对于AMD特殊类型如息肉状脉络膜血管病变和视网膜血管瘤样增生症的治疗方案尚需进一步探索。
作者 俞慧燕 邵彦
机构地区 大连医科大学附属第二医院眼科
出处 《国际眼科纵览》 2006年第4期234-237,共4页 International Review of Ophthalmology
关键词 黄斑变性/治疗 脉络膜新生血管/治疗 光化学疗法
分类号 R774.5 [医药卫生—眼科] R454.2 [医药卫生—治疗学]
  • 相关文献

参考文献4

  • 1张美霞,陆方,严密,张军军,孟丹,杜彩凤,沈齐,王顺清,廖晋英.光动力疗法治疗渗出型老年性黄斑变性四年临床观察总结[J].中华眼底病杂志,2004,20(5):275-279. 被引量：53
  • 2Faik Gelisken,Werner Inhoffen,Khakima Karim-Zoda,Salvatore Grisanti,Michael Partsch,Michael Voelker,Karl Ulrich Bartz-Schmidt. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization[J] 2005,Graefe’s Archive for Clinical and Experimental Ophthalmology(3):198～203
  • 3Rufino M. Silva,José R. Faria de Abreu,António Travassos,José G. Cunha-Vaz. Stabilization of visual acuity with photodynamic therapy in eyes with chorioretinal anastomoses[J] 2004,Graefe’s Archive for Clinical and Experimental Ophthalmology(5):368～376
  • 4G. Theodossiadis,D. Panagiotidis,I. Georgalas,M. Moschos,P. Theodossiadis. Retinal hemorrhage after photodynamic therapy in patients with subfoveal choroidal neovascularization caused by age-related macular degeneration[J] 2003,Graefe’s Archive for Clinical and Experimental Ophthalmology(1):13～18

二级参考文献12

  • 1Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy
  • 2Treatment of Age-related Macular Degeneration with Photodynamic Therapy Study Group; Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for
  • 3Bressler SB, Pieramici DJ, Koester JM, et al. Natural history of minimally classic subfoveal choroidal neovascular lesions in the treatment of age-related macular degeneration with photodynamic therapy (TAP) investigation: outcomes potentially relevant to
  • 4Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analy
  • 5Treatment of Age-related macular degeneration with Photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trial
  • 6Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in agerelated macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neov
  • 7Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol, 1998,43:134-146.
  • 8Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration:results of a randomized clinical trial. Arch Ophthalmol, 1991,109:1220-1231.
  • 9Bressler NM, Rosenfeld PJ, VIM Group. A phase Ⅱ placebo-controlled, double-masked randomized trial: verteporfin in minimally classic a CNV due to AMD(VIM)[abstract]. In: 2003 annual meeting abstract and program planner of the association for research in
  • 10Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trial

共引文献52

同被引文献96

引证文献7

二级引证文献34

国际眼科纵览
2006年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部